OPXS Optex Systems Holdings Inc
Optical Instruments & Lenses · Nasdaq · SEC CIK 1397016 · Fiscal year ends 09/28
Financial factors as of 2026-06-28 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.8%
TTM net income YoY-24.3%
TTM EPS YoY-26.7%
Revenue 3-yr CAGR17.8%
Net income 3-yr CAGR29.1%
Margins
Gross margin30.7%
Operating margin13.2%
Net margin9.8%
FCF margin3.7%
EBITDA margin14.3%
Returns
ROE15.3%
ROA12.6%
ROIC (approx.)22.3%
Asset turnover1.29x
Leverage & solvency
Liabilities / assets14.6%
Debt / equity0.00x
Current ratio7.09x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.66x
Accruals ratio4.3%
Payout ratio—
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-28 | FY20242024-09-29 |
|---|---|---|
| Income statement | ||
| Revenue | $41.34M | $33.99M |
| Cost of revenue | $29.28M | $24.47M |
| Gross profit | $12.06M | $9.53M |
| SG&A expense | $4.92M | $4.71M |
| Operating income | $7.13M | $4.82M |
| Interest expense | -$23,000 | $47,000 |
| Pretax income | $6.35M | $4.77M |
| Income tax | $1.20M | $1.01M |
| Net income | $5.15M | $3.77M |
| EBITDA | $7.65M | $5.31M |
| EPS (basic) | 0.75 | 0.56 |
| EPS (diluted) | 0.74 | 0.55 |
| Weighted avg. shares (diluted) | 6.92M | 6.83M |
| Banking | ||
| Net interest income | $23,000 | -$47,000 |
| Balance sheet | ||
| Cash & equivalents | $6.39M | $1.01M |
| Receivables | $4.57M | $3.76M |
| Inventory | $14.32M | $14.86M |
| Current assets | $25.71M | $20.07M |
| PP&E, net | $1.43M | $1.29M |
| Intangibles | — | $951,000 |
| Total assets | $30.06M | $25.52M |
| Current liabilities | $4.56M | $4.95M |
| Total liabilities | $5.76M | $6.71M |
| Shareholders' equity | $24.29M | $18.81M |
| Shares outstanding | 6.92M | 6.87M |
| Cash flow statement | ||
| Operating cash flow | $6.93M | $1.78M |
| Capital expenditure | $494,000 | $681,000 |
| Free cash flow | $6.44M | $1.10M |
| Investing cash flow | -$504,000 | -$1.73M |
| Financing cash flow | -$1.05M | -$245,000 |
| Depreciation & amortization | $515,000 | $487,000 |
| Stock-based compensation | $383,000 | $425,000 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.